⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3715919 | 1.00 | — | — | |
| SCHEMBL13878074 | 1.00 | — | — | |
| SCHEMBL3715923 | 1.00 | — | — | |
| SCHEMBL15139338 | 1.00 | — | — | |
| SCHEMBL13884218 | 1.00 | — | — | |
| SCHEMBL14374928 | 0.92 | — | — | |
| SCHEMBL14374927 | 0.92 | — | — | |
| SCHEMBL14375013 | 0.91 | — | — | |
| SCHEMBL14385048 | 0.89 | — | — | |
| SCHEMBL13877930 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3208269-B1 | INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA NV (BE) | 2021-09-15 | — | — | EP | disclosed |